Paolo Emanuele Levi Setti
Rozzano, MI, 20089, Italy
NCT Number: NCT04253470
The association between serum progesterone (P) levels, measured on the day of ovulation trigger, and the outcome of in vitro fertilization cycles, has been one of the major controversies in the field of ovarian stimulation endocrinology.
This is a single-center retrospective cohort study. Study duration period is from January 2012 to December 2016.
All fresh embryo transfer (ET) both at cleavage stage and blastocyst stage, performed in Humanitas Fertility Center during the study period, were included.
Looking for future studies?
Notify Me18 year–45 year
Female
Observational
Rozzano, MI, 20089, Italy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Step of the assisted reproduction in which embryos are placed into the uterus in order to obtain a pregnancy
Time frame: January 2012-December 2016
To evaluate the impact of premature high serum P levels on the outcome of fresh embryo transfer cycles in terms of Clinical Pregnancy Rates (CPR) and Live Birth Rates (LBR).
Time frame: January 2012-December 2016
Furthermore, the present study retrospectively investigates whether the transfer of blastocysts on day 5 post-fertilization (D5-ET) may improve the CPR and the LBR in patients with P rise.
Istituto Clinico Humanitas
Other
The Neverending Debate on Progesterone Elevation: Possible Solutions
Acronym: PE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03677336
Dydrogesterone, Female Urogenital Diseases
Jette, Brussels Capital, Belgium
View Trial DetailsNCT07173361
Female, Healthy Volunteers
Hamilton, Ontario, Canada
View Trial DetailsNCT05742503
Contraceptive Methods, Progesterone
Tanta, El-Gharbia, Egypt
View Trial DetailsNCT05276531
Progesterone
Istanbul, Turkey (Türkiye)
View Trial Details